Simplex Trading’s Edgewise Therapeutics EWTX Stock Holding History

Simplex Trading’s Portfolio EWTX Stock Details EWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.4K	Sell	900 -3,800	-81%	-$110K	﹤0.01%	6447
2025 Q4	$117K	Buy	4,700 +2,700	+135%	+$54.2K	﹤0.01%	4840
2025 Q3	$32K	Buy	2,000 +800	+67%	+$11.3K	﹤0.01%	6905
2025 Q2	$15K	Sell	1,200 -134,700	-99%	-$1.94M	﹤0.01%	7001
2025 Q1	$2.99M	Buy	135,900 +123,900	+1,033%	+$3.25M	﹤0.01%	1666
2024 Q4	$320K	Sell	12,000 -56,700	-83%	-$1.81M	﹤0.01%	4000
2024 Q3	$1.83M	Buy	68,700 +62,900	+1,084%	+$1.25M	﹤0.01%	2347
2024 Q2	$104K	Buy	5,800 +5,600	+2,800%	+$97.7K	﹤0.01%	5332
2024 Q1	$3K	Sell	200 -17,200	-99%	-$273K	﹤0.01%	8247
2023 Q4	$190K	Buy	+17,400	New	+$122K	﹤0.01%	4735

Other funds holding EWTX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's EWTX Position: Q1 2026 in Review

Simplex Trading reduced its Edgewise Therapeutics (EWTX) stake by 80% in Q1 2026, selling an estimated $209K and leaving 1,832 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5717.

Simplex Trading first reported a position in EWTX in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.98M in Q3 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

Simplex Trading held 1,832 shares of Edgewise Therapeutics worth $57.7K as of Q1 2026.
Simplex Trading sold 7,237 Edgewise Therapeutics shares in Q1 2026, an estimated $209K.
Edgewise Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5717 holding.
Simplex Trading first reported a position in Edgewise Therapeutics in Q1 2023 and has held it in 11 quarters since.
Simplex Trading's Edgewise Therapeutics position peaked at $1.98M in Q3 2024.
214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.